27/03/2015 - 11:36

Australian-first cancer equipment comes to WA

27/03/2015 - 11:36

Bookmark

Save articles for future reference.

Western Australian cancer researchers seeking to improve radiation therapy have received a $500,000 grant from BHP Billiton.

QE II medical precinct.

Western Australian cancer researchers seeking to improve radiation therapy have received a $500,000 grant from BHP Billiton.

Announced at a Cancer Council WA lunch held today in Perth, president George Yeoh said the money had been spent on a cutting-edge X-RAD radiation platform, the first of its kind in Australia.

Local cancer researchers from Telethon Kids Institute, Harry Perkins Institute of Medical Research, The University of Western Australia, Curtin University, Princess Margaret Hospital and Sir Charles Gairdner Hospital will all be able to use the instrument.

It will be housed at the QEII medical precinct.

Professor Yeoh said researchers using the radiation platform would aim to improve radiation therapy for some of the less common, but more serious cancers, such as brain tumours and bladder cancer.

“The impact of access to this technology cannot be underestimated,” he said.

“This radiation platform is already used in other world-leading research centres, including the US National Cancer Institute, Dana Farber Cancer Institute and Netherlands Cancer Institute, so it will provide a quantum leap in the ability of cancer researchers in WA to develop new therapeutic approaches to cancer based around radiotherapy.”

Professor Yeoh said having the rare equipment would attract cancer national and international researchers to collaborate with WA-based researchers.

“Thanks to BHP Billiton’s investment, this equipment will connect researchers from diverse fields, from laboratory scientists, child and adult oncologists, to radiation oncologists and physicists, all with the goal of improving cancer outcomes,” he said.

BHP Billiton Iron Ore senior manager, community and indigenous affairs, Richard O’Connell, said the company was pleased to be able to support researchers across the country work on ground breaking cancer research.

“This important piece of equipment will have wide spread benefits for the community, including those in the regional communities in which we operate,” he said.

Today was also the announcement of the Cancer Council Awards and 2015 grant recipients.

Three WA cancer researchers have been recognised for their significant achievements in Cancer Council Western Australia’s Research Excellence Awards, just the second time the accolades have been given to recognise the work of cancer researchers in WA. 

The Research Excellence Awards attract a cash prize for each researcher to contribute to their work, and are the only ones to recognise the achievements of those working in the cancer research field in WA across three categories: early career cancer researcher of the year; cancer researcher of the year; and cancer research career achievement award.

Prue Cormie, who is a past Cancer Council postdoctoral research fellow and an accredited exercise physiologist from Edith Cowan University’s Health & Wellness Institute, has been awarded the early career cancer researcher of the year award for her work investigating the role of exercise in the management of cancer. Dr Cormie has pioneered work in identifying exercise as an effective way of counteracting sexual dysfunction following prostate cancer treatment.

Academic haematologist Wendy Erber, who heads the University of Western Australia School of Pathology and Laboratory Medicine, has been awarded cancer researcher of the year.

Her achievements include work in translating scientific and research discoveries into diagnostic pathology practice to improve patient care and outcomes.

The cancer research career achievement award has gone to Bill Musk, who is a clinical rofessor in the Schools of Medicine and Population Health at the University of WA and a respiratory physician at the Sir Charles Gairdner Hospital. He has quietly championed the cause of people affected by asbestos-related diseases over his 35-year career.

Professor Musk is internationally recognised as a leader in research into malignant mesothelioma, asbestosis and lung cancer, and was instrumental in establishing the Asbestos Review Program in WA and the Mesothelioma Register within the Department of Health WA.

Today, the Cancer Council also announced a $3.8 million injection into WA cancer research – the largest amount the council has provided in annual research grants.

Among the successful grant recipients was Carolyn McIntyre from Edith Cowan University who was awarded a $225,000 postdoctoral fellowship over three years to investigate how effective exercise can be in improving the lives of people living with the deadly lung cancer mesothelioma.

Other areas of cancer research to be funded include;

  • investigating carcinomas of unknown primary (CUP);
  • developing automated patient positioning to improve the accuracy of prostate cancer radiation therapy;
  • research to determine the importance of immune cells and molecules in Luminal B breast cancer; and
  • determining whether mammographic density is a strong predictor of breast cancer risk in WA Aboriginal women.

 

 

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options